Tech Company Inital Public Offerings

Oncobiologics IPO

Oncobiologics was purchased by . Shares became public on 5/13/2016.

Transaction Overview

Company Name
Announced On
5/13/2016
Transaction Type
IPO
Amount
$34,800,000
Proceeds Purpose
We currently intend to use the net proceeds from this offering as follows: approximately $20.0 million to advance clinical development of ONS-3010 through Phase 3 clinical trials; approximately $5.0 million to fund our other ongoing research and development activities, including advancing development of ONS-1045 to be ready to enter a Phase 3 clinical trial, and advancing development of ONS-1050 and ONS-4010 to be ready to enter Phase 1 clinical trials; and the remainder for working capital and general corporate purposes.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
7 Clarke Dr.
Cranbury, NJ 08512
USA
Email Address
Overview
Oncobiologics is committed to advancing biotherapeutics to treat serious diseases, including cancer and immune disorders through the development of both novel molecules using the TRIDENT� platform and biosimilar monocolonal antibodies.
Profile
Oncobiologics LinkedIn Company Profile
Social Media
Oncobiologics Company Twitter Account
Company News
Oncobiologics News
Facebook
Oncobiologics on Facebook
YouTube
Oncobiologics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Lawrence Kenyon
  Lawrence Kenyon LinkedIn Profile  Lawrence Kenyon Twitter Account  Lawrence Kenyon News  Lawrence Kenyon on Facebook
Chief Medical Officer
Kenneth Bahrt
  Kenneth Bahrt LinkedIn Profile  Kenneth Bahrt Twitter Account  Kenneth Bahrt News  Kenneth Bahrt on Facebook
VP - Bus. Development
Stephen McAndrew
  Stephen McAndrew LinkedIn Profile  Stephen McAndrew Twitter Account  Stephen McAndrew News  Stephen McAndrew on Facebook
VP - Manufacturing
Chuck Hart
  Chuck Hart LinkedIn Profile  Chuck Hart Twitter Account  Chuck Hart News  Chuck Hart on Facebook
VP - Regulatory Affairs
Myrna Thomas
  Myrna Thomas LinkedIn Profile  Myrna Thomas Twitter Account  Myrna Thomas News  Myrna Thomas on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/13/2016: Monica + Andy venture capital transaction
Next: 5/13/2016: Wickr venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary